COMT rs4633: Understanding Genetic Links to Pain Sensitivity
The rs4633 variant is a common genetic marker located within the COMT gene, which provides instructions for making an enzyme that breaks down neurotransmitters. It is frequently studied in conjunction with other COMT variants to understand how genetic differences may influence individual variations in pain sensitivity.
What each genotype means
Standard enzyme stability profile
This genotype is often associated with the high-activity COMT haplotype. Research suggests that individuals with this profile may have different pain sensitivity thresholds compared to those with the T allele, and some studies have linked this genotype to variations in analgesic requirements. Please discuss any concerns regarding medication dosing or pain management with your clinician or pharmacist.
This is a common genotype found in a significant portion of the global population.
Intermediate enzyme stability profile
Carrying one copy of each allele may result in intermediate COMT enzyme stability. Some research indicates that individuals with this genotype may require different analgesic doses compared to those with the CC genotype, particularly in the context of chronic pain management. Please consult your healthcare provider or pharmacist regarding any medication-related questions.
This heterozygous genotype is frequently observed across diverse ancestral populations.
Altered enzyme stability profile
This genotype is associated with the T allele, which has been studied for its potential influence on COMT enzyme stability and expression levels. Some research has explored associations between this genotype and increased susceptibility to certain health conditions, though findings are often mixed and context-dependent. Always discuss medication dosing and health concerns with your clinician or pharmacist.
This genotype is common, though its prevalence varies significantly across different ancestral groups.
What is rs4633 and Where is it Located?
The rs4633 variant is a single nucleotide polymorphism (SNP) found within the catechol-O-methyltransferase (COMT) gene, which is located on chromosome 22. In the context of genetic research, rs4633 is often analyzed as part of a group of variants that form specific haplotypes. A haplotype is a set of DNA variations that tend to be inherited together because they are physically close to one another on the same chromosome. Because rs4633 is in linkage disequilibrium with other well-known COMT variants, such as rs4680 (commonly known as Val158Met), researchers often use it as a tag to help identify these broader genetic patterns. While rs4633 itself is a synonymous variant—meaning it does not change the amino acid sequence of the resulting protein—its proximity to functional variants makes it a valuable tool for scientists mapping the genetic architecture of the COMT gene.
The Role of the COMT Gene
The COMT gene encodes the catechol-O-methyltransferase enzyme, which plays a critical role in the nervous system by breaking down catecholamine neurotransmitters, including dopamine, epinephrine, and norepinephrine. By clearing these chemicals from the synaptic space between neurons, the COMT enzyme helps regulate the intensity and duration of signaling in the brain and peripheral nervous system. Because these neurotransmitters are heavily involved in mood regulation, cognitive function, and the processing of pain signals, the efficiency of the COMT enzyme is a subject of intense scientific interest. Variations in the COMT gene can lead to differences in enzyme stability or activity levels. When the enzyme is less efficient, catecholamines may remain in the synapse for longer periods, potentially altering how an individual perceives or responds to various physiological and psychological stressors.
Research on Pain Sensitivity
For nearly two decades, the COMT gene has been a primary focus in pain genetics research. Studies have suggested that specific COMT haplotypes—combinations of variants including rs4633 and rs4680—may correlate with differences in pain sensitivity and the efficacy of certain pain treatments. Some research indicates that individuals with certain genetic profiles may experience higher sensitivity to thermal or sustained pain, potentially due to differences in how their bodies modulate opioid system activation. However, it is important to note that the evidence is mixed. While some studies report significant associations, others have found inconsistent results, suggesting that the impact of these variants may be influenced by other factors such as sex, psychological stress, and the specific type of pain stimulus. Consequently, while COMT variants are recognized as genetic markers of interest, they are not considered definitive predictors of an individual's pain experience.
What You Can and Cannot Do With This Information
Understanding your genetic variants can be an educational experience, but it is essential to maintain realistic expectations regarding what this information means for your health. Genetic markers like rs4633 provide insight into biological predispositions, but they do not act as diagnostic tools. Pain is a complex, multifaceted experience influenced by a vast array of environmental, psychological, and biological factors beyond a single SNP. You cannot use this information to diagnose a condition or predict your personal pain threshold with certainty. If you are concerned about chronic pain or are considering changes to your pain management regimen, it is vital to consult with a qualified healthcare provider or pharmacist. They can help you interpret your health history in a clinical context and ensure that any decisions regarding medication or treatment are based on comprehensive medical evidence rather than isolated genetic data.
How common is this variant?
The rs4633 variant is considered common, with a minor allele frequency (MAF) of approximately 40% across many global populations.
Frequently asked questions
Is rs4633 a diagnostic test for pain?
No, rs4633 is not a diagnostic test. It is a genetic marker used in research to study biological trends, but it cannot predict an individual's personal pain threshold or diagnose any medical condition.
Does my genotype mean I will feel more pain?
Not necessarily. While some research links COMT variants to differences in pain sensitivity, these associations are complex and influenced by many other factors, including environment and overall health. Genetic markers are only one small piece of the puzzle.
Should I change my medication based on my COMT genotype?
You should never change your medication based on genetic information without professional guidance. Always discuss your medications and any concerns about pain management with your doctor or pharmacist.
Why is rs4633 studied with Val158Met?
These variants are located close together on the same gene and are often inherited as a block, known as a haplotype. Studying them together helps researchers better understand the functional impact of the COMT gene.
Sources & further reading
Educational information only, last refreshed 10/9/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs4633?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in COMT
Intronic regulatory polymorphism in COMT linked in haplotype studies to altered dopamine turnover and executive function.
Part of the central COMT haploblock regulating catecholamine breakdown and modifying pain sensitivity profiles.
Synonymous variant in COMT in linkage disequilibrium with Val158Met, influencing enzyme stability and pain sensitivity.
Non-coding COMT single nucleotide polymorphism that modulates prefrontal cortical catecholamine degradation and interacts with stress exposure on cognitive performance.
COMT Val158Met ('warrior/worrier') variant affecting dopamine tone and stress resilience.
Intronic tag SNP in linkage disequilibrium with functional catechol-O-methyltransferase activity variations, frequently studied in pain perception and neuropsychiatric endophenotypes.